stella
beta
Carvedilol + Simvastatin vs. Carvedilol Alone for Cirrhosis and Cirrhotic Cardiomyopathy and Impact on Hepatic Decompensation and Survival — Stella
Home
/
Decompensated Cirrhosis
/
Carvedilol + Simvastatin vs. Carvedilol Alone for Cirrhosis and Cirrhotic Cardiomyopathy and Impact on Hepatic Decompensation and Survival
View on ClinicalTrials.gov
Recruiting
Back to Decompensated Cirrhosis trials
Carvedilol + Simvastatin vs. Carvedilol Alone for Cirrhosis and Cirrhotic Cardiomyopathy and Impact on Hepatic Decompensation and Survival
Not a traditional drug trial — this study doesn't follow the standard phase structure.
Trial locations
(1 site)
India
PGIMER, Department of Hepatology, Chandigarh
Follow this trial
Get notified in plain English when this trial's status changes. No account required.
Follow